Robertet SA header image

Robertet SA

RBT

Equity

ISIN FR0000039091 / Valor 510354

Euronext - Euronext Paris (2025-10-20)
EUR 825.00+0.86%

Robertet SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Robertet SA is a global company known for its expertise in providing natural flavors, fragrances, and ingredients for health and beauty products. With a focus on sustainability and organic raw materials, Robertet integrates all stages of the creative process from seed to release. The company's partnership with Sonarome, a family-owned company based in Bangalore, enhances its R&D capabilities and local market knowledge, further solidifying its position as an innovative and responsible leader in the industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (11.10.2025):

Robertet SA reported strong financial performance for the fiscal year 2024, demonstrating continued growth and resilience in a challenging market environment.

12% Organic Growth

The company achieved a sustained organic growth of 12% at constant exchange rates, driven by robust sales across all divisions and regions.

Geographical Expansion

Particularly strong performances were observed in new markets such as Asia, Latin America, and the Middle East, significantly contributing to the overall growth.

Enhanced Operating Margin

Robertet SA not only increased its sales but also improved its operating margin, reflecting effective cost management and operational efficiency.

Summarized from source with an LLMView Source

Key figures

-14.8%1Y
-3.51%3Y
-16.0%5Y

Performance

17.8%1Y
19.0%3Y
21.4%5Y

Volatility

Market cap

1874 M

Market cap (USD)

Daily traded volume (Shares)

836

Daily traded volume (Shares)

1 day high/low

862 / 853

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 44.12
Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.17%EUR 86.58
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.21%EUR 63.90
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 163523
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%USD 83.87
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.23%EUR 48.37
Asker Healthcare Group AB
Asker Healthcare Group AB Asker Healthcare Group AB Valor: 143378021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%SEK 84.94
Dynavox Group AB
Dynavox Group AB Dynavox Group AB Valor: 114900704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.39%SEK 102.70
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.40%USD 64.64
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Valor: 30132056
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.40%USD 27.07
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.67%CHF 59.92